Tele-monitoring reduces exacerbation of COPD in the context of climate change–a randomized controlled trial

Table 1 Patient baseline characteristics (N = 62)

Group	TG	CG	P-Value
N	32	30
Gender (male/female)	26/6	22/8	.79
Age (years)	64.1 ± 10.9	69.1 ± 9.2	.27
BMI (kg/m ² )	27.6 ± 6.7	27.0 ± 4.9	.87
Resting SpO ₂ Saturation	95.4 ± 1.7	94.3 ± 3.6	.095
FEV ₁ (%)	50.2 ± 15.0	52.6 ± 17.5	.731
PEF (L/min)	3.7 ± 1.23	4.4 ± 1.4	.194
MMRC	1.9 ± 1.1	1.2 ± 0.93	.125
GOLD	2.6 ± 0.8	2.5 ± 0.9	.83
BODE	3.2 ± 3.1	2.9 ± 3.0	.55
SGRQ	51.3 ± 18.7	48.7 ± 14.7	.56
COPD Medication
Long AC	25 (78%)	22 (73%)	.33
ICS/LABA	23 (72%)	21 (70%)	.46

Characteristics of patient population; data is presented as Mean ± SD; group comparisons of measurements across between Tele-monitoring group (TG) and control group (CG) were done using a two tailed student’s t-test and χ²-test. BMI = Body Mass Index; SpO₂ = resting oxygen saturation; FEV₁ (L) = Forced Expiratory Volume in one second; PEF = Peak Expiratory Flow; MMRC = Modified Medical Research Council Dyspnea Scale; SGRQ = St. George Respiratory Questionnaire; Long AC = Long Acting Anticholinergic; ICS/LABA = fix combination of ICS/LABA.

ISSN: 1476-069X